PTPRC and neoplasm: The tumor-infiltrating myeloid cell population comprised CD103+CD11chi dendritic cells (3.6%, 95 CI = 2.5%–4.7%), CD11b+CD11chi dendritic cells (5.8%, 95 CI = 4.2%–7.4%), B220+CD11c+ plasmacytoid dendritic cells (7.6%, 95 CI = 3.3%–11.0%), CD11b+Gr1−F4/80+ macrophages (51.4%, 95 CI = 42%–61%) and CD11b+Gr1+ MDSC (6.7%, 95 CI = 3.6%–9.8%).